There is no evidence that medicinal cannabis is an effective treatment for cancer. You may apply for other conditions however, you will need to supply clinical evidence with your application for this to be considered.
palliative care (cachexia, nausea and vomiting, pain). some types of epilepsy with severe seizures. chemotherapy-induced nausea and vomiting. severe muscular spasms and other symptoms of multiple sclerosis. The scientific evidence base is limited but suggests that medicinal cannabis may be suitable for: More research is being done on the uses of medicinal cannabis. THC, CBD, or THC and CBD in combination) for your patient's medical condition or symptoms. When making an application to the TGA, you will need to reference clinical evidence that supports using the specific type of medicinal cannabis product proposed (e.g. The Medicines and Poisons Act 2019 provides for the development of departmental standards which outline the minimum requirements for safe and effective management of regulated substances, including medicinal cannabis, review the standards for more information. The Medicines and Poisons (Medicines) Regulation 2021 outlines specific requirements for dealing with regulated substances, including medicinal cannabis, review the Regulation for more information. The individual documents can be viewed on the TGA's website. Guidance’s for the use of medicinal cannabis in Australia are a suite of national guidance documents that cover a range of medical conditions, symptoms, and products to be used. Queensland doctors can prescribe Schedule 4 - cannabidiol (CBD) and Schedule 8 - tetrahydrocannabinol (THC) or tetrahydrocannabinol: cannabidiol (THC:CBD) products without a Queensland approval. Read more about Prescribing and dispensing unregistered medicinal cannabis products (PDF 165 kB) In Queensland, the Medicines and Poisons (Medicines) Regulation 2021 describes the requirements for prescribing and dispensing S4 and S8 medicines. The Commonwealth Department of Health manages and enables access to: In circumstances where patients need access to therapeutic goods that are not included in the ARTG, a Therapeutic Goods Administration (TGA) approval is required in order for the medicine to be prescribed. Medicinal cannabis products are classified as either Schedule 3, Schedule 4 or Schedule 8 controlled substances, most products are not listed on the Australian Register of Therapeutic Goods (ARTG). Any registered medical practitioner in Queensland can prescribe medicinal cannabis for any patient with any condition, if they believe it is clinically appropriate and have obtained the required Commonwealth approval.
0 kommentar(er)
